COVID-19患者-话题@MedSci

#COVID-19患者#

185篇内容 | 3980人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1297438, encodeId=c90a129e4388b, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=Science：【聚焦】为什么COVID-19患者在缺氧状态下还感到很舒服？, objectType=article, longId=193212, objectId=2f8f19321249, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f8f19321249, replyNumber=0, likeNumber=127, createdTime=2020-05-01, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f8f19321249, moduleTitle=Science：【聚焦】为什么COVID-19患者在缺氧状态下还感到很舒服？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f8f19321249)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297437, encodeId=e3b3129e4371f, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=瑞德西韦治疗重症住院COVID-19患者III期临床数据公开, objectType=article, longId=193204, objectId=9f0e19320472, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f0e19320472, replyNumber=0, likeNumber=59, createdTime=2020-05-01, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f0e19320472, moduleTitle=瑞德西韦治疗重症住院COVID-19患者III期临床数据公开, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f0e19320472)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297436, encodeId=843d129e436a9, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=Clin Gastroenterol H：腹泻与COVID-19患者症状和病毒携带时间延长有关 , objectType=article, longId=193041, objectId=2eb7193041d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2eb7193041d6, replyNumber=0, likeNumber=64, createdTime=2020-04-28, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2eb7193041d6, moduleTitle=Clin Gastroenterol H：腹泻与COVID-19患者症状和病毒携带时间延长有关 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2eb7193041d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297435, encodeId=ccce129e4350c, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=II期临床试验测试Vafidemstat治疗重症COVID-19患者的疗效, objectType=article, longId=193033, objectId=b12819303320, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b12819303320, replyNumber=0, likeNumber=59, createdTime=2020-04-28, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b12819303320, moduleTitle=II期临床试验测试Vafidemstat治疗重症COVID-19患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b12819303320)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297433, encodeId=3342129e43348, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=C5抑制剂Ultomiris（ravulizumab-cwvz）治疗重症COVID-19患者的临床试验：即将开展, objectType=article, longId=192701, objectId=46b6192e01ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46b6192e01ae, replyNumber=0, likeNumber=67, createdTime=2020-04-23, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46b6192e01ae, moduleTitle=C5抑制剂Ultomiris（ravulizumab-cwvz）治疗重症COVID-19患者的临床试验：即将开展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46b6192e01ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297432, encodeId=07c3129e4326f, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=QRB Discovery ：MIT开发出新蛋白，或可阻止COVID-19患者出现细胞因子风暴, objectType=article, longId=192633, objectId=87911926336f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87911926336f, replyNumber=0, likeNumber=72, createdTime=2020-04-22, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87911926336f, moduleTitle=QRB Discovery ：MIT开发出新蛋白，或可阻止COVID-19患者出现细胞因子风暴, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87911926336f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297431, encodeId=fbd4129e43126, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=J Thromb Haemost：COVID-19患者血小板减少症与死亡率的关系, objectType=article, longId=192508, objectId=a0bb192508e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0bb192508e2, replyNumber=0, likeNumber=90, createdTime=2020-04-20, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0bb192508e2, moduleTitle=J Thromb Haemost：COVID-19患者血小板减少症与死亡率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0bb192508e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297430, encodeId=8b8f129e430d8, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=COV-ENT-1治疗COVID-19患者的随机I / IIa期临床试验：即将开始, objectType=article, longId=192485, objectId=767f19248570, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=767f19248570, replyNumber=0, likeNumber=57, createdTime=2020-04-20, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=767f19248570, moduleTitle=COV-ENT-1治疗COVID-19患者的随机I / IIa期临床试验：即将开始, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=767f19248570)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297429, encodeId=7718129e4294c, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=除了发热，嗅觉和味觉丧失也是COVID-19患者的早期症状，且恢复率高！, objectType=article, longId=192377, objectId=3f351923e7f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f351923e7f2, replyNumber=0, likeNumber=61, createdTime=2020-04-17, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f351923e7f2, moduleTitle=除了发热，嗅觉和味觉丧失也是COVID-19患者的早期症状，且恢复率高！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f351923e7f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297428, encodeId=ef17129e42804, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=JAK抑制剂Olumiant和抗血管生成素-2单抗LY3127804将用于新冠病毒COVID-19患者临床试验, objectType=article, longId=192249, objectId=f473192249cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f473192249cd, replyNumber=0, likeNumber=81, createdTime=2020-04-16, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f473192249cd, moduleTitle=JAK抑制剂Olumiant和抗血管生成素-2单抗LY3127804将用于新冠病毒COVID-19患者临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f473192249cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297427, encodeId=7959129e42745, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=Eur Respir J：湖北省内外COVID-19患者临床特征和结局差异, objectType=article, longId=192047, objectId=f28d19204e19, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f28d19204e19, replyNumber=0, likeNumber=57, createdTime=2020-04-13, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f28d19204e19, moduleTitle=Eur Respir J：湖北省内外COVID-19患者临床特征和结局差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f28d19204e19)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297426, encodeId=8352129e4263b, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=Feinstein研究所收集COVID-19患者血浆，研究抗体疗法, objectType=article, longId=192018, objectId=a05b1920187a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a05b1920187a, replyNumber=0, likeNumber=61, createdTime=2020-04-13, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a05b1920187a, moduleTitle=Feinstein研究所收集COVID-19患者血浆，研究抗体疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a05b1920187a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297425, encodeId=c78e129e425f5, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=NEJM：重磅！雷地西韦治疗重症Covid-19患者临床结果公布, objectType=article, longId=192014, objectId=e0d41920140e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0d41920140e, replyNumber=0, likeNumber=67, createdTime=2020-04-13, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0d41920140e, moduleTitle=NEJM：重磅！雷地西韦治疗重症Covid-19患者临床结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0d41920140e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297434, encodeId=89fa129e434c2, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=意大利1591例进入ICU的COVID-19患者的特征和临床结局, objectType=article, longId=191865, objectId=f7fd1918655c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7fd1918655c, replyNumber=0, likeNumber=66, createdTime=2020-04-11, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7fd1918655c, moduleTitle=意大利1591例进入ICU的COVID-19患者的特征和临床结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7fd1918655c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297424, encodeId=ca57129e424f8, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=JAMA：意大利1591例进入ICU的COVID-19患者的特征和临床结局, objectType=article, longId=191827, objectId=572319182e1e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=572319182e1e, replyNumber=0, likeNumber=68, createdTime=2020-04-10, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=572319182e1e, moduleTitle=JAMA：意大利1591例进入ICU的COVID-19患者的特征和临床结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=572319182e1e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297423, encodeId=5091129e42357, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=武汉金银谭医院的临床研究证实，lopinavir-ritonavir抗HIV组合可减轻新冠COVID-19患者症状, objectType=article, longId=191735, objectId=0487191e35a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0487191e35a3, replyNumber=0, likeNumber=49, createdTime=2020-04-10, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0487191e35a3, moduleTitle=武汉金银谭医院的临床研究证实，lopinavir-ritonavir抗HIV组合可减轻新冠COVID-19患者症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0487191e35a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297422, encodeId=b61b129e422ad, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=吉利德宣布开展remdesivir治疗中重度新冠病毒COVID-19患者的两项III期试验, objectType=article, longId=191476, objectId=71041914e630, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71041914e630, replyNumber=0, likeNumber=70, createdTime=2020-04-06, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71041914e630, moduleTitle=吉利德宣布开展remdesivir治疗中重度新冠病毒COVID-19患者的两项III期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71041914e630)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297421, encodeId=b460129e42101, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=JAK抑制剂ruxolitinib治疗重度COVID-19患者：正在进行评估, objectType=article, longId=191368, objectId=f47919136872, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f47919136872, replyNumber=0, likeNumber=69, createdTime=2020-04-05, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f47919136872, moduleTitle=JAK抑制剂ruxolitinib治疗重度COVID-19患者：正在进行评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f47919136872)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297420, encodeId=e695129e4204c, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=小型临床研究证实：抗疟疾药物可改善COVID-19患者症状, objectType=article, longId=191299, objectId=45a41912996f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45a41912996f, replyNumber=0, likeNumber=72, createdTime=2020-04-04, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45a41912996f, moduleTitle=小型临床研究证实：抗疟疾药物可改善COVID-19患者症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45a41912996f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297419, encodeId=9fde129e41908, content=<a href='/topic/show?id=c0385134ab' target=_blank style='color:#2F92EE;'>#COVID-19患者#</a>, objectTitle=Lancet Infect Dis: 唾液中2019-nCOV的检测及COVID-19患者的口腔症状, objectType=article, longId=191178, objectId=6e591911e89b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e591911e89b, replyNumber=0, likeNumber=63, createdTime=2020-04-02, rootId=0, userName=zhangph, userId=6976269, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e591911e89b, moduleTitle=Lancet Infect Dis: 唾液中2019-nCOV的检测及COVID-19患者的口腔症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e591911e89b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

COVID-19患者

2020-05-29

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

Science：【聚焦】为什么COVID-19患者在缺氧状态下还感到很舒服？

2020-05-01

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

瑞德西韦治疗重症住院COVID-19患者III期临床数据公开

2020-05-01

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

Clin Gastroenterol H：腹泻与COVID-19患者症状和病毒携带时间延长有关

2020-04-28

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

II期临床试验测试Vafidemstat治疗重症COVID-19患者的疗效

2020-04-28

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

C5抑制剂Ultomiris（ravulizumab-cwvz）治疗重症COVID-19患者的临床试验：即将开展

2020-04-23

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

QRB Discovery ：MIT开发出新蛋白，或可阻止COVID-19患者出现细胞因子风暴

2020-04-22

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

J Thromb Haemost：COVID-19患者血小板减少症与死亡率的关系

2020-04-20

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

COV-ENT-1治疗COVID-19患者的随机I / IIa期临床试验：即将开始

2020-04-20

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

除了发热，嗅觉和味觉丧失也是COVID-19患者的早期症状，且恢复率高！

2020-04-17

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

JAK抑制剂Olumiant和抗血管生成素-2单抗LY3127804将用于新冠病毒COVID-19患者临床试验

2020-04-16

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

Eur Respir J：湖北省内外COVID-19患者临床特征和结局差异

2020-04-13

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

Feinstein研究所收集COVID-19患者血浆，研究抗体疗法

2020-04-13

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

NEJM：重磅！雷地西韦治疗重症Covid-19患者临床结果公布

2020-04-13

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

意大利1591例进入ICU的COVID-19患者的特征和临床结局

2020-04-11

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

JAMA：意大利1591例进入ICU的COVID-19患者的特征和临床结局

2020-04-10

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

武汉金银谭医院的临床研究证实，lopinavir-ritonavir抗HIV组合可减轻新冠COVID-19患者症状

2020-04-10

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

吉利德宣布开展remdesivir治疗中重度新冠病毒COVID-19患者的两项III期试验

2020-04-06

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

JAK抑制剂ruxolitinib治疗重度COVID-19患者：正在进行评估

2020-04-05

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

小型临床研究证实：抗疟疾药物可改善COVID-19患者症状

2020-04-04

zhangph (审核中...)

前往app查看评论内容

#COVID-19患者#

Lancet Infect Dis: 唾液中2019-nCOV的检测及COVID-19患者的口腔症状

2020-04-02

科室
- - 订阅+
  - 更多科室
工具
服务